首页> 外文期刊>The Journal of rheumatology >Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
【24h】

Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

机译:慢性痛风的治疗。我们能否确定何时排空足够的尿液以防止痛风发作?

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine if lowering of serum uric acid (SUA) concentrations below 6 mg/dl or longer duration of lowered SUA will result in depletion of urate crystals from the knee joints and prevent further attacks of gout. METHODS: A prospective study was initiated 10 years ago at Philadelphia VA Medical Center to attempt to maintain SUA levels of patients with crystal proven gout at < 6.0 mg/dl. We recalled all 57 patients who were available during 1999. Patients were divided into 2 groups: Group A, with SUA still > 6 mg/dl, and Group B, with SUA < or = 6 mg/dl. A knee joint aspirate was requested from all asymptomatic Group B patients and many in Group A. Aspirates were examined by polarized light microscopy for identification of crystals. RESULTS: There were no differences between the groups in age, sex, duration of gout, or serum creatinine. Group A (n = 38) had a mean of 6 attacks of gout for the recent year, those with tophi having the most frequent attacks. Among the 16 patients in this group who agreed to knee aspiration, monosodium urate (MSU) crystals were found in 14, although they were asymptomatic at the time. Nineteen patients (Group B) were able to maintain serum urate levels < or = 6 mg/dl for > 12 months. Nearly half of them had no attack of gout for 2 or more years, with a mean of 1 attack in the last year for the whole group. Three patients in whom tophi were found did not have major flares of gout within the past year. Knee joint aspiration was done on 16 asymptomatic patients. Seven (44%) still had MSU crystals present in their knees. Patients in this group who were taking prophylactic colchicine did not differ with respect to the character of synovial fluid from those who had discontinued it for up to several years, although the frequency of attacks was less in those who continued colchicine. CONCLUSION: A majority of patients were able to deplete urate crystal stores in their knee joint fluids when their SUA levels were kept to < or = 6 mg/dl for several years. The mechanisms for persistence in some patients, and whether such crystals have clinical implications, are not known. Patients with chronic gout need serum urate concentrations to be kept low to prevent further attacks.
机译:目的:确定降低血清尿酸(SUA)浓度是否低于6 mg / dl或持续降低SUA的持续时间是否会导致膝关节中尿酸盐结晶的消耗并防止痛风的进一步发作。方法:一项前瞻性研究于10年前在费城VA医疗中心开始,目的是将晶体确诊的痛风患者的SUA水平维持在<6.0 mg / dl。我们回顾了1999年可使用的所有57例患者。患者分为两组:A组,SUA仍> 6 mg / dl,B组,SUA <或= 6 mg / dl。所有无症状的B组患者和A组中的许多患者都要求膝关节抽吸物。通过偏振光显微镜检查抽吸物以鉴定晶体。结果:两组之间的年龄,性别,痛风持续时间或血清肌酐无差异。 A组(n = 38)最近一年平均有6次痛风发作,其中患有痛风石的患者发作次数最多。在该组同意膝盖抽吸术的16例患者中,有14例发现尿酸单钠(MSU)晶体,尽管当时无症状。 19名患者(B组)能够在12个月内维持血清尿酸盐水平≤6 mg / dl。他们中将近一半没有痛风发作2年或更长时间,去年整个人群平均有1次发作。在过去的一年中,发现三名痛风石的患者没有严重的痛风发作。对16例无症状患者进行了膝关节抽吸术。仍有七个(44%)的膝盖上存在MSU晶体。在该组中,服用预防性秋水仙碱的患者与滑液停药长达数年的患者在滑液特性上没有差异,尽管继续服用秋水仙碱的患者发作频率较低。结论:大多数患者将SUA水平维持在≤6 mg / dl数年后,便能耗尽膝关节液中的尿酸盐晶体。某些患者的持久性机制以及此类晶体是否具有临床意义尚不清楚。患有慢性痛风的患者需要将血清尿酸盐浓度保持在较低水平,以防止进一步发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号